SCHEMBL7423019

SCHEMBL7423019

O=C1Nc2ccccc2C1=Cc1n[nH]cc1CCl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.49
GSK3B P49841 1/20 0.48
TLK2 Q86UE8 3/20 0.47
MAPT P10636 2/20 0.46
CDK5 Q00535 1/20 0.46
PTK2B Q14289 1/20 0.46
CDK5R1 Q15078 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
NPC1 O15118 1/20 0.46
PLK4 O00444 1/20 0.46
PLK1 P53350 1/20 0.46
KDR P35968 1/20 0.46
SYK P43405 1/20 0.46
ATM Q13315 1/20 0.46
RET P07949 1/20 0.46
FLT3 P36888 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001444 0.83 GSK3B (0.51) ALKGSK3BTLK2MAPTCDK5
SCHEMBL6001442 0.83 GSK3B (0.51) ALKGSK3BTLK2MAPTCDK5
SCHEMBL7423015 0.70 KDR (0.60) ALKGSK3BTLK2MAPTPTK2B
SCHEMBL5728617 0.70 FLT3 (0.63) ALKGSK3BTLK2MAPTCDK5
SCHEMBL5728618 0.70 FLT3 (0.63) ALKGSK3BTLK2MAPTCDK5
SCHEMBL6001525 0.70 GSK3B (0.62) ALKGSK3BTLK2MAPTCDK5
SCHEMBL6001522 0.70 GSK3B (0.62) ALKGSK3BTLK2MAPTCDK5
SCHEMBL578229 0.69 CDK5 (0.58) ALKGSK3BTLK2MAPTCDK5
SCHEMBL578228 0.69 CDK5 (0.58) ALKGSK3BTLK2MAPTCDK5
SCHEMBL6000982 0.69 GSK3B (0.61) ALKGSK3BTLK2MAPTCDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883116-A ANTITUMOR AGENTS AND ENZYME INHIBITORS SUGEN, INC. (US) 1999-03-16 US disclosed
EP-0769947-A4 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN INC (US) 1998-09-30 EP disclosed
EP-0769947-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE Sugen, Inc. (US) 1997-05-02 EP disclosed
WO-1996040116-A1 INDOLINONE COMPOUNDS FOR THE TREATMENT OF DISEASE SUGEN, INC. (US) 1996-12-19 WO disclosed